Live from the NIH registry
Studies recruiting near Aurora right now
Top 25 of 615 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Loyola University Medical Center (Adults and Pediatrics) — Maywood, Illinois (24.4 mi)
· Sponsor: Pierre Fabre Medicament
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Edward-Elmhurst Cancer Center /ID# 238552 — Elmhurst, Illinois (20.3 mi)
· Sponsor: AbbVie
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Dr. Sudarshan K. Sharma, Ltd. — Hinsdale, Illinois (18.4 mi)
· Sponsor: Kartos Therapeutics, Inc.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Advocate Outpatient Center - Aurora — Aurora, Illinois (1.6 mi)
· Sponsor: NRG Oncology
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Hinsdale, Illinois (18.4 mi)
· Sponsor: AstraZeneca
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi)
· Sponsor: SCRI Development Innovations, LLC
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Midwest Digestive Health & Nutrition — Des Plaines, Illinois (28.0 mi)
· Sponsor: Eli Lilly and Company
Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
Healthy Adult
N/A
Interventional 34 participants sought
Biofortis Clinical Research — Addison, Illinois (19.4 mi)
· Sponsor: Shaklee Corporation
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
Pancreatic Cancer
Phase 2
Interventional 60 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (7.1 mi)
· Sponsor: Proton Collaborative Group
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Rush-Copley Medical Center — Aurora, Illinois (1.6 mi)
· Sponsor: SWOG Cancer Research Network
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
University Retina and Macula Associates, PC — Lemont, Illinois (16.1 mi)
· Sponsor: Genentech, Inc.
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Alzheimers Disease, Dementia
Phase 2, Phase 3
Interventional 280 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.8 mi)
· Sponsor: Washington University School of Medicine
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Phase 3
Interventional 428 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (7.1 mi)
· Sponsor: NRG Oncology
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10025, Naperville, IL — Naperville, Illinois (7.5 mi)
· Sponsor: Colorado Prevention Center
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Solid Tumours
Phase 2
Interventional 588 participants sought
Illinois Cancer Specialists — Arlington Heights, Illinois (27.5 mi)
· Sponsor: Boehringer Ingelheim
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50717 — Willowbrook, Illinois (18.3 mi)
· Sponsor: UCB Biopharma SRL
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Perinatal Decision Making
N/A
Interventional 2,200 participants sought
Rush Copley Medical Center — Aurora, Illinois (1.6 mi)
· Sponsor: Endeavor Health
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Complex Regional Pain Syndrome Type I
Phase 3
Interventional 270 participants sought
Ambros Clinical Trial Site — Orland Park, Illinois (24.3 mi)
· Sponsor: Ambros Therapeutics, Inc.
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Southwest Gastroenterology — Oak Lawn, Illinois (27.7 mi)
· Sponsor: Ardelyx
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Prostate Cancer
N/A
Interventional 70 participants sought
Northwestern Medicine Chicago Proton Center — Warrenville, Illinois (7.1 mi)
· Sponsor: Proton Collaborative Group
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
Fox Valley Clinical Research Center, LLC — Aurora, Illinois (1.6 mi)
· Sponsor: Uppsala University
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer
Phase 2
Interventional 99 participants sought
Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois (7.1 mi)
· Sponsor: Genentech, Inc.
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
Advocate Lutheran General Hospital — Park Ridge, Illinois (28.8 mi)
· Sponsor: M.A. Med Alliance S.A.
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Recurrent Glioblastoma, IDH-Wildtype, Recurrent MGMT-Methylated Glioblastoma
Phase 1, Phase 2
Interventional 97 participants sought
University of Chicago Medicine-Orland Park — Orland Park, Illinois (24.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Phase 3
Interventional 500 participants sought
Local Institution - 1148 — Elgin, Illinois (18.9 mi)
· Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company